InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: BonnieMac post# 142039

Friday, 02/11/2022 10:42:25 AM

Friday, February 11, 2022 10:42:25 AM

Post# of 198947
I thought I'd seen a document somewhere that described the difference in more sciencey terms, but offhand my guess is the difference is in secondary ingredients only, since IPF is the active ingredient.

...the Enzolytics product is similar in composition to the immunomodulator offered by Rosetta under the trademark “Enzoimmune Active”...

...Both products are based on the same biotechnology platform (IPF), patented by the Zhabilov Trust (US Patent No. 8,309,072).

https://rosettalifecarebg.org/cooperation-between-enzolytics-inc-and-rosetta-lifecare-bulgaria-in-advanced-phase/



Since the companies are working together now, I don't understand why they wouldn't take one or the other formulation to streamline production.